{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,8,23]],"date-time":"2022-08-23T20:10:31Z","timestamp":1661285431612},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2018,5,16]],"date-time":"2018-05-16T00:00:00Z","timestamp":1526428800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["HNO"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1007\/s00106-018-0513-6","type":"journal-article","created":{"date-parts":[[2018,5,16]],"date-time":"2018-05-16T10:16:36Z","timestamp":1526465796000},"page":"419-431","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Komplikationen und Nebenwirkungen bei konservativer Therapie rhinologischer Erkrankungen"],"prefix":"10.1007","volume":"66","author":[{"given":"I.","family":"K\u00fcster","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Rudack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Beule","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,5,16]]},"reference":[{"key":"513_CR1","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1159\/000313185","volume":"5","author":"R Weber","year":"1995","unstructured":"Weber R, Keerl R, Draf W, Wienke A, Kind M (1995) Zur Begutachtung: Periorbitales Paraffingranulom nach Nasennebenh\u00f6hlenoperation. Otorhinolaryngol Nova 5:87\u201390","journal-title":"Otorhinolaryngol. Nova"},{"key":"513_CR2","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1055\/s-2004-825695","volume":"83","author":"AG Beule","year":"2004","unstructured":"Beule AG, Weber RK, Kaftan H, Hosemann W (2004) \u00dcbersicht: Art und Wirkung gel\u00e4ufiger Nasentamponaden. Laryngorhinootologie 83:534\u2013551","journal-title":"Laryngorhinootologie"},{"key":"513_CR3","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1055\/s-0042-108445","volume":"95","author":"M Ganso","year":"2016","unstructured":"Ganso M, Goebel R, Melhorn S, Schrenk D, Schulz M (2016) Lipidpneumonie durch Lipid-haltige Nasensprays und -tropfen. Laryngorhinootologie 95:534\u2013539","journal-title":"Laryngorhinootologie"},{"key":"513_CR4","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1007\/s00405-013-2362-y","volume":"270","author":"C Hahn","year":"2013","unstructured":"Hahn C, B\u00f6hm M, Allekotte S, M\u00f6sges R (2013) Tolerability and effects on quality of life of liposomal nasal spray treatment compared to nasal ointment containing dexpanthenol or isotonic NaCl spray in patients with rhinitis sicca. Eur Arch Otorhinolaryngol 270:2465\u20132472","journal-title":"Eur. Arch. Otorhinolaryngol."},{"key":"513_CR5","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/j.ijporl.2014.04.026","volume":"78","author":"JR Chen","year":"2014","unstructured":"Chen JR, Jin L, Li XY (2014) The effectiveness of nasal saline irrigation (seawater) in treatment of allergic rhinitis in children. Int J Pediatr Otorhinolaryngol 78:1115\u20131118","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"513_CR6","volume-title":"Rhinosinusitis S2k-Leitlinie. Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF)- St\u00e4ndige Kommission Leitlinien","year":"2017","unstructured":"Stuck BA (Hrsg) (2017) Rhinosinusitis S2k-Leitlinie. Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF)- St\u00e4ndige Kommission Leitlinien. http:\/\/www.awmf.org\/uploads\/tx_szleitlinien\/017-049_und_053-012l_S2k_Rhinosinusitis_2017-12.pdf . Zugegriffen: 28. Jan. 2018"},{"key":"513_CR7","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1097\/00005537-200007000-00023","volume":"110","author":"LT Tomooka","year":"2000","unstructured":"Tomooka LT, Murphy C, Davidson TM (2000) Clinical study and literature review of nasal irrigation. Laryngoscope 110:1189\u20131193","journal-title":"Laryngoscope"},{"key":"513_CR8","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011995.pub2","author":"LY Chong","year":"2016","unstructured":"Chong LY, Head K, Hopkins C, Philpott C, Glew S, Scadding G, Burton MJ, Schilder AGM (2016) Saline irrigation for chronic rhinosinusitis (Review). Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD011995.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"513_CR9","first-page":"691","volume-title":"Gelbe Liste Online der Medizinische Medien Informations GmbH","author":"M Jurasovic","year":"2018","unstructured":"Jurasovic M, Bouvier V (2018) Gelbe Liste Online der Medizinische Medien Informations GmbH. https:\/\/www.gelbe-liste.de . (letzte \u00c4nderung 01.03.2018)"},{"key":"513_CR10","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.ijporl.2011.12.022","volume":"76","author":"JS Jeffe","year":"2012","unstructured":"Jeffe JS, Bhushan B, Schroeder JW (2012) Nasal saline irrigation in children: a study of compliance and tolerance. Int J Pediatr Otorhinolaryngol 76:409\u2013413","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"513_CR11","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1093\/cid\/cis626","volume":"55","author":"JS Yoder","year":"2012","unstructured":"Yoder JS, Straif-Bourgeois S, Roy SL, Moore TA, Visvesvara GS, Ratard RC, Hill VR, Wilson JD, Linscott AJ, Crager R, Kozak NA, Sriram R, Narayanan J, Mull B, Kahler AM, Schneeberger C, da Silva AJ, Poudel M, Baumgarten KL, Xiao L, Beach MJ (2012) Primary amebic meningoencephalitis deaths associated with sinus irrigation using contaminated tap water. Clin Infect Dis 55:79\u201385","journal-title":"Clin Infect Dis"},{"key":"513_CR12","doi-asserted-by":"publisher","first-page":"2891","DOI":"10.1007\/s00405-013-2398-z","volume":"270","author":"J Campos","year":"2013","unstructured":"Campos J, Heppt W, Weber R (2013) Nasal douches for diseases of the nose and the paranasal sinuses\u2014a\u00a0comparative in vitro investigation. Eur Arch Otorhinolaryngol 270:2891\u20132899","journal-title":"Eur. Arch. Otorhinolaryngol."},{"key":"513_CR13","doi-asserted-by":"publisher","first-page":"516","DOI":"10.3390\/ijerph14050516","volume":"14","author":"N Principi","year":"2017","unstructured":"Principi N, Esposito S (2017) Nasal irrigation: an imprecisely defined medical procedure. Int J Environ Res Public Health 14:516","journal-title":"Int J Environ Res Public Health"},{"key":"513_CR14","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1007\/978-3-662-50351-5_42","volume-title":"Arzneiverordnungs-Report 2016","year":"2016","unstructured":"Schwabe U, Paffrath D (Hrsg) (2016) Arzneiverordnungs-Report 2016. Springer, Berlin Heidelberg, Kapitel 42 (Rhinologika und Otologika):691\u2013696"},{"key":"513_CR15","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1055\/s-0029-1246124","volume":"89","author":"AG Beule","year":"2010","unstructured":"Beule AG (2010) Funktionen und Funktionsst\u00f6rungen der respiratorischen Schleimhaut der Nase und der Nasennebenh\u00f6hlen. Laryngorhinootologie 89:15\u201334","journal-title":"Laryngorhinootologie"},{"key":"513_CR16","first-page":"159","volume":"5","author":"M Archontaki","year":"2009","unstructured":"Archontaki M, Symvoulakis EK, Hajiioannou JK, Stamou AK, Kastrinakis S, Bizaki AJ, Kyrmizakis DE (2009) Increased frequency of rhinitis medicamentosa due to media advertising for nasal topical decongestants. B\u2011ENT 5:159\u2013162","journal-title":"B-ENT"},{"key":"513_CR17","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1097\/00005537-200104000-00008","volume":"111","author":"P Merkus","year":"2001","unstructured":"Merkus P, Romeijn SG, Verhoef JC, Merkus FW, Schouwenburg PF (2001) Classification of cilio-inhibiting effects of nasal drugs. Laryngoscope 111:595\u2013602","journal-title":"Laryngoscope"},{"key":"513_CR18","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.otohns.2003.07.005","volume":"130","author":"B Marple","year":"2004","unstructured":"Marple B, Peter R, Benninger M (2004) Safety review of benzalkonium chloride used as a\u00a0preservative in intranasal solutions: an overview of conflicting data and opinions. Otolaryngol Head Neck Surg 130:95\u2013118","journal-title":"Otolaryngol. Head Neck Surg."},{"key":"513_CR19","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1093\/aje\/kws427","volume":"178","author":"WP Yau","year":"2013","unstructured":"Yau WP, Mitchell AA, Lin KJ, Werler MM, Hern\u00e1ndez-D\u00edaz S (2013) Use of decongestants during pregnancy and the risk of birth defects. Am J Epidemiol 178:198\u2013208","journal-title":"Am J Epidemiol"},{"key":"513_CR20","volume-title":"Arzneimittelsicherheit in Schwangerschaft und Stillzeit. www.embryotox.de. (letzte \u00c4nderung: 30.03.2018)","author":"C Borisch","year":"2018","unstructured":"Borisch C, Padberg S, Hoeltzenbein M, Oppermann M, Fritzsche J, Hultzsch S et\u00a0al (2018) Arzneimittelsicherheit in Schwangerschaft und Stillzeit. www.embryotox.de . (letzte \u00c4nderung: 30.03.2018)"},{"key":"513_CR21","doi-asserted-by":"publisher","first-page":"339","DOI":"10.2500\/ajra.2015.29.4223","volume":"29","author":"DM Poetker","year":"2015","unstructured":"Poetker DM (2015) Oral corticosteroids in the management of chronic rhinosinusitis with and without nasal polyps: risks and benefits. Am J Rhinol Allergy 29:339\u2013342","journal-title":"Am J Rhinol Allergy"},{"key":"513_CR22","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1111\/cea.12953","volume":"47","author":"GK Scadding","year":"2017","unstructured":"Scadding GK, Kariyawasam HH, Scadding G, Mirakian R, Buckley RJ, Dixon T, Durham SR, Farooque S, Jones N, Leech S, Nasser SM, Powell R, Roberts G, Rotiroti G, Simpson A, Smith H, Clark AT (2017) BSACI guideline for the diagnosis and management of allergic and non-allergic rhinitis. Clin Exp Allergy 47:856\u2013889","journal-title":"Clin Exp Allergy"},{"key":"513_CR23","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1177\/014556130808700812","volume":"87","author":"MS Benninger","year":"2008","unstructured":"Benninger MS (2008) Epistaxis and its relationship to handedness with use of intranasal steroid spray. Ear Nose Throat\u00a0J 87:463\u2013465","journal-title":"Ear Nose Throat J"},{"key":"513_CR24","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.otohns.2003.10.007","volume":"130","author":"MS Benninger","year":"2004","unstructured":"Benninger MS, Hadley JA, Osguthorpe JD, Marple BF, Leopold DA, Derebery MJ, Hannley M (2004) Techniques of intranasal steroid. Otolaryngol Head Neck Surg 130:5\u201324","journal-title":"Otolaryngol. Head Neck Surg."},{"key":"513_CR25","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2500\/ajra.2015.29.4111","volume":"29","author":"MM Verkerk","year":"2015","unstructured":"Verkerk MM, Bhatia D, Rimmer J, Earls P, Sacks R, Harvey RJ (2015) Intranasal steroids and the myth of mucosal atrophy: a systematic review of original histological assessments. Am J Rhinol Allergy 29:3\u201318","journal-title":"Am J Rhinol Allergy"},{"key":"513_CR26","first-page":"1","volume":"22","author":"J Sastre","year":"2012","unstructured":"Sastre J, Mosges R (2012) Local and systemic safety of intranasal corticosteroids. J\u00a0Investig Allergol Clin Immunol 22:1\u201312","journal-title":"J Investig Allergol Clin Immunol"},{"key":"513_CR27","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/0002-9343(85)90046-4","volume":"79","author":"R Kimmerle","year":"1985","unstructured":"Kimmerle R, Rolla AR (1985) Iatrogenic Cushing\u2019s syndrome due to dexamethasone nasal drops. Am J Med 79:535\u2013537","journal-title":"Am J Med"},{"key":"513_CR28","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s001060050439","volume":"47","author":"M Fuchs","year":"1999","unstructured":"Fuchs M, Wetzig H, Kertscher F, T\u00e4schner R, Keller E (1999) Iatrogenes Cushing-Syndrom und Mutatio tarda durch Dexamethason-haltige Nasentropfen. HNO 47:647\u2013650","journal-title":"HNO"},{"key":"513_CR29","doi-asserted-by":"publisher","first-page":"157","DOI":"10.4274\/Jcrpe.726","volume":"4","author":"D Dutta","year":"2012","unstructured":"Dutta D, Ks S, Ghosh S, Mukhopadhyay S, Chowdhury S (2012) Case report short-term intranasal steroid use. J\u00a0Clin Res Pediatr Endocrinol 4:157\u2013159","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"513_CR30","first-page":"97","volume":"4","author":"F Dursun","year":"2017","unstructured":"Dursun F, Kirmizibekmez H (2017) Iatrogenic Cushing\u2019s syndrome caused by intranasal steroid use. North Clin Istanb 4:97\u201399","journal-title":"North. Clin. Istanb."},{"key":"513_CR31","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1159\/000216193","volume":"16","author":"FM Bruni","year":"2009","unstructured":"Bruni FM, De Luca G, Venturoli V, Boner AL (2009) Intranasal corticosteroids and adrenal suppression. Neuroimmunomodulation 16:353\u2013362","journal-title":"Neuroimmunomodulation"},{"key":"513_CR32","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1067\/mai.2000.110038","volume":"106","author":"DB Allen","year":"2000","unstructured":"Allen DB (2000) Systemic effects of intranasal steroids: an endocrinologist\u2019s perspective. J\u00a0Allergy Clin Immunol 106:179\u2013190","journal-title":"J Allergy Clin Immunol"},{"key":"513_CR33","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1542\/peds.105.2.e22","volume":"105","author":"EJ Schenkel","year":"2000","unstructured":"Schenkel EJ, Skoner DP, Bronsky EA, Miller SD, Pearlman DS, Rooklin A, Rosen JP, Ruff ME, Vandewalker ML, Wanderer A, Damaraju CV, Nolop KB, Mesarina-Wicki B (2000) Absence of growth retardation in children with perennial allergic rhinitis after one year of treatment with mometasone furoate aqueous nasal spray. Pediatrics 105:22","journal-title":"Pediatrics"},{"key":"513_CR34","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/S0091-6749(98)70275-1","volume":"102","author":"AM Wilson","year":"1998","unstructured":"Wilson AM, Sims EJ, McFarlane LC, Lipworth BJ (1998) Effects of intranasal corticosteroids on adrenal, bone, and blood markers of systemic activity in allergic rhinitis. J\u00a0Allergy Clin Immunol 102:598\u2013604","journal-title":"J Allergy Clin Immunol"},{"key":"513_CR35","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1007\/s00774-010-0255-3","volume":"29","author":"O Emin","year":"2011","unstructured":"Emin O, Fatih M, Emre D, Nedim S (2011) Lack of bone metabolism side effects after 3 years of nasal topical steroids in children with allergic rhinitis. J\u00a0Bone Miner Metab 29:582\u2013587","journal-title":"J Bone Miner Metab"},{"key":"513_CR36","doi-asserted-by":"publisher","first-page":"311","DOI":"10.3928\/01913913-20101018-03","volume":"48","author":"E Ozkaya","year":"2011","unstructured":"Ozkaya E, Ozsutcu M, Mete F (2011) Lack of ocular side effects after 2 years of topical steroids for allergic rhinitis. J\u00a0Pediatr Ophthalmol Strabismus 48:311\u2013317","journal-title":"J Pediatr Ophthalmol Strabismus"},{"key":"513_CR37","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1016\/j.jaci.2005.07.031","volume":"116","author":"CM Bui","year":"2005","unstructured":"Bui CM, Chen H, Shyr Y, Joos KM (2005) Discontinuing nasal steroids might lower intraocular pressure in glaucoma. J\u00a0Allergy Clin Immunol 116:1042\u20131047","journal-title":"J Allergy Clin Immunol"},{"key":"513_CR38","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011991.pub2","author":"K Head","year":"2016","unstructured":"Head K, Chong LY, Hopkins C, Philpott C, Burton MJ, Schilder AG (2016) Short-course oral steroids alone for chronic rhinosinusitis (Review). Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD011991.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"513_CR39","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1016\/j.jaci.2010.02.020","volume":"125","author":"T Zele Van","year":"2010","unstructured":"Van Zele T, Gevaert P, Holtappels G, Beule A, Wormald PJ, Mayr S, Hens G, Hellings P, Ebbens FA, Fokkens W, Van Cauwenberge P, Bachert C (2010) Oral steroids and doxycycline: two different approaches to treat nasal polyps. J\u00a0Allergy Clin Immunol 125:1069\u20131076","journal-title":"J Allergy Clin Immunol"},{"key":"513_CR40","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.jaci.2006.03.012","volume":"118","author":"P Hissaria","year":"2006","unstructured":"Hissaria P, Smith W, Wormald PJ, Taylor J, Vadas M, Gillis D, Kette F (2006) Short course of systemic corticosteroids in sinonasal polyposis: a double-blind, randomized, placebo-controlled trial with evaluation of outcome measures. J\u00a0Allergy Clin Immunol 118:128\u2013133","journal-title":"J Allergy Clin Immunol"},{"key":"513_CR41","doi-asserted-by":"crossref","first-page":"525","DOI":"10.4193\/Rhino11.140","volume":"49","author":"V Kirtsreesakul","year":"2011","unstructured":"Kirtsreesakul V, Wongsritrang K, Ruttanaphol S (2011) Clinical efficacy of a\u00a0short course of systemic steroids in nasal polyposis. Rhinology 49:525\u2013532","journal-title":"Rhinology"},{"key":"513_CR42","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008115.pub3","author":"RP Venekamp","year":"2014","unstructured":"Venekamp RP, Thompson MJ, Hayward G, Heneghan CJ, Del Mar CB, Perera R, Glasziou PP, Rovers MM (2014) Systemic corticosteroids for acute sinusitis. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD008115.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"513_CR43","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1001\/jama.2014.14418","volume":"313","author":"RP Venekamp","year":"2015","unstructured":"Venekamp RP, Thompson MJ, Rovers MM (2015) Systemic corticosteroid therapy for acute sinusitis. J\u00a0Am Med Assoc 313:1258","journal-title":"J Am Med Assoc"},{"key":"513_CR44","doi-asserted-by":"publisher","first-page":"22","DOI":"10.2500\/ajra.2017.31.4396","volume":"31","author":"JR Scott","year":"2017","unstructured":"Scott JR, Ernst HM, Rotenberg BW, Rudmik L, Sowerby LJ (2017) Oral corticosteroid prescribing habits for rhinosinusitis: the American Rhinologic Society membership. Am J Rhinol Allergy 31:22\u201326","journal-title":"Am J Rhinol Allergy"},{"key":"513_CR45","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.bjorl.2017.01.002","volume":"83","author":"OG Mion","year":"2017","unstructured":"Mion OG, Mello JF Jr, Dutra DL, Andrade NA, Almeida WL, Anselmo-Lima WT, Filho LL, Carvalho E, Castro J, Guimar\u00e3es RE, Lessa MM, Maniglia SF, Meireles RC, Nakanishi M, Pignatari SS, Roithmann R, Romano FR, Santos RP, Santos MC, Tamashiro E (2017) Position statement of the Brazilian Academy of Rhinology on the use of antihistamines, antileukotrienes, and oral corticosteroids in the treatment of inflammatory sinonasal diseases. Braz J Otorhinolaryngol 83:215\u2013227","journal-title":"Braz J Otorhinolaryngol"},{"key":"513_CR46","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011992.pub2","author":"K Head","year":"2016","unstructured":"Head K, Chong LY, Hopkins C, Philpott C, Schilder AG, Burton MJ (2016) Short-course oral steroids as an adjunct therapy for chronic rhinosinusitis. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD011992.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"513_CR47","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1016\/S0091-6749(95)70213-X","volume":"95","author":"EO Meltzer","year":"1995","unstructured":"Meltzer EO (1995) An overview of current pharmacotherapy in perennial rhinitis. J\u00a0Allergy Clin Immunol 95:1097\u20131110","journal-title":"J Allergy Clin Immunol"},{"key":"513_CR48","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1592\/phco.27.6.852","volume":"27","author":"TA Lee","year":"2007","unstructured":"Lee TA, Pickard AS (2007) Meta-analysis of azelastine nasal spray for the treatment of allergic rhinitis. Pharmacotherapy 27:852\u2013859","journal-title":"Pharmacotherapy"},{"key":"513_CR49","doi-asserted-by":"publisher","first-page":"405","DOI":"10.7326\/0003-4819-132-5-200003070-00011","volume":"132","author":"S Hennessy","year":"2000","unstructured":"Hennessy S, Strom BL (2000) Nonsedating antihistamines should be preferred over sedating antihistamines in patients who drive. Ann Intern Med 132:405\u2013407","journal-title":"Ann Intern Med"},{"key":"513_CR50","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1007\/s40629-014-0009-1","volume":"23","author":"J Ring","year":"2014","unstructured":"Ring J, Beyer K, Biedermann T, Bircher A, Duda D, Fischer J, Friedrichs F, Fuchs T, Gieler U, Jakob T, Klimek L, Lange L, Merk HF, Niggemann B, Pfaar O, Przybilla B, Ru\u00ebff F, Rietschel E, Schnadt S, Seifert R, Sitter H, Varga EM, Worm M, Brockow K (2014) Guideline for acute therapy and management of anaphylaxis. Allergo J Int 23:96\u2013112","journal-title":"Allergo J Int"},{"key":"513_CR51","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1177\/2042098616658399","volume":"7","author":"SL Gray","year":"2016","unstructured":"Gray SL, Hanlon JT (2016) Anticholinergic medication use and dementia: latest evidence and clinical implications. Ther Adv Drug Saf 7:217\u2013224","journal-title":"Ther Adv Drug Saf"},{"key":"513_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0119551","volume":"10","author":"E Poluzzi","year":"2015","unstructured":"Poluzzi E, Raschi E, Godman B, Koci A, Moretti U, Kalaba M, Wettermark B, Sturkenboom M, De Ponti F (2015) Pro-arrhythmic potential of oral antihistamines (H1): combining adverse event reports with drug utilization data across Europe. PLoS ONE 10:1\u201314","journal-title":"PLoS ONE"},{"key":"513_CR53","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/j.clinthera.2009.05.017","volume":"31","author":"C Bachert","year":"2009","unstructured":"Bachert C (2009) A review of the efficacy of desloratadine, fexofenadine, and levocetirizine in the treatment of nasal congestion in patients with allergic rhinitis. Clin Ther 31:921\u2013944","journal-title":"Clin Ther"},{"key":"513_CR54","first-page":"182","volume":"12","author":"C Bachert","year":"2003","unstructured":"Bachert C, Borchard U, Wedi B, Klimek L, Rasp G, Riechelmann H, Schultze-Werninghaus G, Wahn U, Ring J (2003) Allergische Rhinokonjunktivitis: Leitlinie der Deutschen Gesellschaft f\u00fcr Allergologie und klinische Immunologie (DGAI). Allergol J 12:182\u2013194","journal-title":"Allergol. J."},{"key":"513_CR55","first-page":"1440","volume":"81","author":"DK Sur","year":"2010","unstructured":"Sur DK, Scandale S (2010) Treatment of allergic rhinitis. Am Fam Physician 81:1440\u20131446","journal-title":"Am Fam Physician"},{"key":"513_CR56","doi-asserted-by":"publisher","DOI":"10.1002\/prp2.341","author":"MG Haarman","year":"2017","unstructured":"Haarman MG, van Hunsel F, de Vries TW (2017) Adverse drug reactions of montelukast in children and adults. Pharmacol Res Perspect 5(5). https:\/\/doi.org\/10.1002\/prp2.341","journal-title":"Pharmacol Res Perspect"},{"key":"513_CR57","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1016\/j.clinthera.2015.03.027","volume":"37","author":"CY Lu","year":"2016","unstructured":"Lu CY, Zhang F, Lakoma MD, Butler MG, Fung V, Larkin EK, Kharbanda EO, Vollmer WM, Lieu T, Soumerai SB, Wu AC (2016) Asthma treatments and mental health visits after a\u00a0food and drug administration label change for leukotriene inhibitors. Clin Ther 37:1280\u20131291","journal-title":"Clin. Ther."},{"key":"513_CR58","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.rmed.2017.07.013","volume":"130","author":"D Bona Di","year":"2017","unstructured":"Di Bona D, Fiorino I, Taurino M, Frisenda F, Minenna E, Pasculli C, Kourtis G, Rucco AS, Nico A, Albanesi M, Giliberti L, D\u2019Elia L, Caiaffa MF, Macchia L (2017) Long-term \u201creal-life\u201d safety of omalizumab in patients with severe uncontrolled asthma: a nine-year study. Respir Med 130:55\u201360","journal-title":"Respir Med"},{"key":"513_CR59","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.3109\/02770903.2015.1081700","volume":"53","author":"A Detoraki","year":"2016","unstructured":"Detoraki A, Di Capua L, Varricchi G, Genovese A, Marone G, Spadaro G (2016) Omalizumab in patients with eosinophilic granulomatosis with polyangiitis: a\u00a036-month follow-up study. J\u00a0Asthma 53:1532\u20134303","journal-title":"J Asthma"},{"key":"513_CR60","doi-asserted-by":"publisher","first-page":"379","DOI":"10.2332\/allergolint.55.379","volume":"55","author":"K Okubo","year":"2006","unstructured":"Okubo K, Ogino S, Nagakura T, Ishikawa T (2006) Omalizumab is effective and safe in the treatment of Japanese cedar pollen-induced seasonal allergic rhinitis. Allergol Int 55:379\u2013386","journal-title":"Allergol Int"}],"container-title":["HNO"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00106-018-0513-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00106-018-0513-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00106-018-0513-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,23]],"date-time":"2022-08-23T19:37:14Z","timestamp":1661283434000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00106-018-0513-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,16]]},"references-count":60,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["513"],"URL":"https:\/\/doi.org\/10.1007\/s00106-018-0513-6","relation":{},"ISSN":["0017-6192","1433-0458"],"issn-type":[{"value":"0017-6192","type":"print"},{"value":"1433-0458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,16]]},"assertion":[{"value":"16 May 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"I.\u00a0K\u00fcster, C.\u00a0Rudack und A.\u00a0Beule geben an, dass kein Interessenkonflikt besteht. Die Autoren erkl\u00e4ren ihre wirtschaftliche Unabh\u00e4ngigkeit bei der Erstellung des Artikels.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"Dieser Beitrag beinhaltet keine von den Autoren durchgef\u00fchrten Studien an Menschen oder Tieren. Alle Patienten, die \u00fcber Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts zu identifizieren sind, haben hierzu ihre schriftliche Einwilligung gegeben. Im Fall von nichtm\u00fcndigen Patienten liegt die Einwilligung eines Erziehungsberechtigten oder des gesetzlich bestellten Betreuers vor.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}}]}}